Q-Pad Test System
K号: K231465 · 2023-12-06
广告
申请人Qurasense
决定日期2023-12-06
产品代码LCP
咨询委员会HE
请注意，由于您只提供了“HE”作为输入，我无法提供完整的翻译。请提供完整的描述或文本，以便我能够进行准确的翻译。
决定实质等同
器械摘要
Q-Pad Test System is the device name listed in this FDA 510(k) record. The listed applicant is Qurasense. It received FDA 510(k) clearance on 2023-12-06 under 510(k) number K231465. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the Q-Pad Test System?
Q-Pad Test System is a medical device that received FDA 510(k) clearance on 2023-12-06. The listed applicant is Qurasense. The 510(k) number is K231465.
When did Q-Pad Test System receive FDA 510(k) clearance?
Q-Pad Test System received FDA 510(k) clearance on 2023-12-06, under 510(k) number K231465.
Who is the listed applicant for Q-Pad Test System?
The FDA 510(k) record lists Qurasense as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Q-Pad Test System?
The FDA product code for Q-Pad Test System is LCP.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：LCP）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K221326Nova Allegro HbA1c检测，Nova Allegro分析仪Nova Biomedical CorporationK214117Afinion™ HbA1c, Afinion™ 2 和 Alere Afinion™ AS100 分析仪Abbott Diagnostics Technologies ASK192987Aina HbA1c监测系统2Jana Care, Inc.K192369PixoTest POCT系统 - PixoTest POCT分析仪和PixoTest A1c测试套件Ixensor Co, Ltd.K183230OneDraw A1C测试系统Drawbridge Health, Inc.K181915PixoTest POCT系统 - PixoTest POCT分析仪和PixoTest A1c测试套件Ixensor Co, Ltd.
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告